What is LOPJLB’s current signal on BIOA?

LOPJLB’s latest quantitative signal on BioAge Labs Inc. (BIOA) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is BIOA in?

BioAge Labs Inc. (BIOA) is currently classified in the CRISIS HMM market regime on LOPJLB.

BioAge Labs Inc. (BIOA)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$6.34+2.09%Close

SELLCRISIS · day 50

RANGE

DATA 2026-10-09

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $239M
Beta: 0.94
P/E (TTM): -2.64

Short % float: 10.34%
Days to cover: 3.9
SI change: +6.5%

1W: -4.08%
1M: -26.71%

vs SPY 1W: -5.25%
vs SPY 1M: -29.70%

Industry peers

FMP comparable companies · ranked by market cap

ALLOSELLAllogene Therapeutics, Inc.$518MCRISISQ -12$1.50+4.29%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The companyâs technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes…

Employees: 61
Headquarters: US
Founded: 2024
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 37.6M
Float: 84.1%

bioagelabs.com ↗

Key executives

Kristen Fortney — Co-Founder, Chief Executive Officer, President, Treasurer, Secretary & Director

Paul D. Rubin — Chief Medical Officer & Executive Vice President of Research

Eric Morgen — Co-Founder, Chief Operating Officer & Director

SEC filings

EDGAR · CIK 17099410 · BIOA

Analyst consensus

Buy

Bullish583.3%

Neutral116.7%

Bearish00.0%

L $21.00Avg $28.67H $40.00

Target$28.67+352.21%

Last$6.34

FAQ

What is LOPJLB’s current signal on BIOA?: LOPJLB’s latest quantitative signal on BioAge Labs Inc. (BIOA) is SELL in a CRISIS regime. Signals are updated daily.
What market regime is BIOA in?: BioAge Labs Inc. (BIOA) is currently classified in the CRISIS HMM market regime on LOPJLB.
What does BioAge Labs Inc. (BIOA) do?: BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The companyâs technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. Its lead product candidate includes BGE-102, an orally available brain-penetrant small-molecule NLRP3 i…

Key stats

Industry peers

Prediction markets

Company news

FAQ